Intraperitoneal injection of Nutlin-3, a p53 activator, ameliorated arthritis dramatically, including a significant decrease in arthritis scores and joint swelling relative to the vehicle-treated group (p < 0.05; Fig. 1a and b). Here, TP53 is linked to arthritic joint disease.